C-Rad AB Earnings Call Transcripts
Fiscal Year 2025
-
Q4 saw a 4% decline in order intake and 6% lower revenue year-on-year, with strong growth in the Americas offset by weakness in APAC. Gross margin improved to 71%, and cash flow remained solid, while the new CEO emphasized disciplined execution and growth.
-
Q3 delivered strong revenue and order intake growth, led by EMEA and services, with operating margin rising to 19%. Gross margin was temporarily high due to one-time items, and cash flow improved significantly. A share repurchase program and new executive team were announced.
-
Order intake grew 11% in constant currencies, led by EMEA and Americas, while revenue declined 13% year-on-year due to a strong comparison period. Operational efficiency improved with a 10% OpEx reduction, and service order intake surged 86%.
-
Solid Q1 performance with 5% order intake growth and 1% revenue increase, driven by EMEA and APAC. EBIT margin (excluding currency effects) improved to 18%, and cash balance rose to SEK 161 million. Medium-term targets include >10% organic growth and 25% operating margin.
Fiscal Year 2024
-
Order intake grew 13% in Q4, with strong APAC performance and improved profitability, though EMEA and Americas faced revenue declines. EBIT margin reached 17% in Q4, and the company ended with a strong cash position and no long-term debt.
-
Q3 saw a 40% drop in order intake and a 10% revenue decline year-over-year, mainly due to EMEA weakness, but profitability and gross margin remained strong, supported by proton order deliveries. APAC and Americas showed growth, and the company maintains a robust balance sheet.
-
Q2 2024 saw 43% revenue growth and a doubling of EBIT, driven by strong global demand and a surge in proton orders, with APAC and China as key contributors. Gross margin reached an exceptional 68% but is expected to normalize, while investments in automation and organizational growth continue.